// App-Quantinova.ai

: BATF3/MYC axis drives hyper-proliferation of TET2 deficient CAR T cells

Researchers

Presenter

  • Nayan Jain

Principal Investigators

  • Zeguo Zhao

  • Archana Iyer

  • Michael Lopez

  • Judith Feucht

  • Richard Koche

  • Julie Yang

  • Yingqian Zhan

  • Michel Sadelain

Medical Centers

  • Univ. of Tuebingen, Germany

  • Memorial Sloan Kettering Cancer...

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Coxsackie Virus And Adenovirus Receptor

  • Tet methylcytosine dioxygenase 2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A